Marksans Pharma standalone net profit rises 17.30% in the September 2021 quarter
Sales rise 22.76% to Rs 168.85 crore
Net profit of Marksans Pharma rose 17.30% to Rs 27.60 crore in the quarter ended September 2021 as against Rs 23.53 crore during the previous quarter ended September 2020. Sales rose 22.76% to Rs 168.85 crore in the quarter ended September 2021 as against Rs 137.55 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales168.85137.55 23 OPM %20.0916.75 -PBDT41.3234.68 19 PBT37.0231.01 19 NP27.6023.53 17Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 10 2021 | 11:21 AM IST